Wingstop Announces Additional $500 Million Share Repurchase Authorization
Get Alerts WING Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.5%
EPS Growth %: +3.0%
Join SI Premium – FREE
"We believe our asset-lite, highly-franchised model enables industry-leading shareholder returns," commented
Repurchases under the program may be made in the open market, in privately negotiated transactions or by other means, including through trading plans intended to qualify under Rule 10b5-1 of the Securities and Exchange Act of 1934 and accelerated share repurchase agreements, with the amount and timing of repurchases to be determined at Wingstop's discretion, depending on market and business conditions, prevailing stock prices, and contractual limitations, among other factors. Open market repurchases will be structured to occur in accordance with applicable federal securities laws. This program does not obligate Wingstop to acquire any particular amount of common stock, or at any specific time or intervals and may be modified, suspended or terminated at any time at Wingstop's discretion.
Wingstop expects to fund repurchases with existing cash and cash equivalents, including the proceeds from its recently completed
About Wingstop
Founded in 1994 and headquartered in
In fiscal year 2023, Wingstop's system-wide sales increased 27.1% to approximately
A key to this business success and consumer fandom stems from
In 2023, Wingstop earned its "Best Places to Work" certification. The Company landed on Entrepreneur Magazine's "Fastest-Growing Franchises" list and ranked #16 on "Franchise 500." Wingstop was listed on Technomic's "Top 500 Chain Restaurant Report," QSR Magazine's "2023 QSR 50" and Franchise Time's "40 Smartest-Growing Franchises."
For more information, visit www.wingstop.com or www.wingstop.com/own-a-wingstop and follow @Wingstop on X, Instagram, Facebook, and TikTok. Learn more about Wingstop's involvement in its local communities at www.wingstopcharities.org. Unless specifically noted otherwise, references to our website addresses, the website addresses of third parties or other references to online content in this press release do not constitute incorporation by reference of the information contained on such website and should not be considered part of this release.
Forward-looking Statements
This news release includes statements of our expectations, intentions, plans and beliefs that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to come within the safe harbor protection provided by those sections. These statements, which involve risks and uncertainties, relate to the discussion of our expectations concerning the implementation and execution of our share repurchase program, including the anticipated execution of a
When considering forward-looking statements in this news release or that we make in other reports or statements, you should keep in mind the cautionary statements in this news release and future reports we file with the SEC. New risks and uncertainties arise from time to time, and we cannot predict when they may arise or how they may affect us. Any forward-looking statement in this news release speaks only as of the date on which it was made. Except as required by law, we assume no obligation to update or revise any forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.
Media Contact
[email protected]
Investor Contact
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/wingstop-announces-additional-500-million-share-repurchase-authorization-302324306.html
SOURCE Wingstop Restaurants Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA clears Merck's Keytruda combo for muscle-invasive bladder cancer
- Silo Pharma launches $4M private placement with warrant upside
- Samos Energy prices IPO of 20M units at $10 each on NYSE
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Stock Buyback, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share